Picture of InnoTherapy logo

246960 InnoTherapy Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for InnoTherapy, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3,989-3,036-5,040-5,972-5,026
Depreciation
Amortisation
Non-Cash Items221-4547291,4761,217
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital81.576-346-365189
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-3,264-2,872-3,983-4,105-2,819
Capital Expenditures-294-1,820-6,343-890-2,899
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-573-2,437-8,1675,9284,431
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-867-4,257-14,5105,0371,532
Financing Cash Flow Items18
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities9,6321,85718,945-1404,510
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5,497-5,2774557913,224